-
Type:
Change Request
-
Resolution: Persuasive with Modification
-
Priority:
Medium
-
US Minimal Common Oncology Data Elements (mCODE) (FHIR)
-
STU3
-
Clinical Interoperability Council
-
(NA)
-
-
Richard Esmond/Kurt Allen: 10-0-1
-
Clarification
-
Non-substantive
Comment:
Not clear if/how provenance is represented in this FHIR Implementation Guide. Provenance (who, what, when, where, why) is essential at: 1) point of origination (at the source, for newly captured content), 2) point of update (for newly updated content, preserving previous content and its provenance).
Who = subject of care/information (typically the patient)
Who = performer of action taken
Who = author of information captured or updated
Who = organization
What = action taken
When = date/time of action taken
When = date/time of information capture or update
Where = physical location of action taken
Where = physical location of information capture or update
Where = network address and/or device ID where information captured or updated
Why = rationale, purpose of action taken
Why = rationale, purpose of information capture or update
Granularity of provenance (e.g., binding authorship to content) may be at the dataset or element level.
Summary:
Unclear how provenance is handled in this IG
- is voted on by
-
BALLOT-10675 Negative - Gary Dickinson : 2019-Sep-FHIR IG MCODE R1
- Balloted